InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,320.60
(
-0.90%
)
Post# of 251715
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 826
Posts 119569
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 187080

Wednesday, 02/11/2015 9:22:51 AM

Wednesday, February 11, 2015 9:22:51 AM

Post# of 251715
ADXS, INCY enter clinical-trial collaboration to test ADXS-HPV with INCY’s IDO1 inhibitor in cervical cancer:

http://finance.yahoo.com/news/advaxis-forms-clinical-trial-collaboration-123000050.html

ADVS has a clinical-trial collaborations AZN (testing ADXS-HPV with MEDI4736 in cervical/H&N cancer) and with MRK (testing ADXS-PSA with Keytruda in CRPC).

ADXS’ most advanced trial is the one being conducted by GOG in cervical cancer (#msg-110322479).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up